MainBoardListed
Tata Capital Limited
Company websiteTata Capital Limited plans to raise ₹47,58,24,280 crore via IPO. That includes a fresh infusion of ₹21,00,00,000 crore and an OFS worth ₹26,58,24,280 crore.
Apply from 06-10-2025 until 08-10-2025. Allotment and tentative listing are scheduled for 09-10-2025 and 13-10-2025. Quick tip: check lot size and valuation before bidding.
Start Date06-10-2025
End Date08-10-2025
Listing Date13-10-2025
Allotment Date09-10-2025
Current Price₹330
GMP₹0 (0.00%)
Lot Size46 Shares
Subscription1.95 Times
Face Value₹10 per share
Listing atNSE, BSE
Issue Price₹310 - ₹326
Pre Issue₹4,03,48,69,037
Post Issue₹4,24,48,69,037
Issue Size₹47,58,24,280
(aggregating up to 15511.87 Cr)
(aggregating up to 15511.87 Cr)
Fresh Issue₹21,00,00,000
(aggregating up to 6846.00 Cr)
(aggregating up to 6846.00 Cr)
Offer For Sale₹26,58,24,280
(aggregating up to 8665.87 Cr)
(aggregating up to 8665.87 Cr)
The Grey Market Premium (GMP) for Tata Capital Limited is currently around ₹0 (0.00%). This indicates an estimated listing price of approximately ₹310 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
21 Nov 2025, 08:58 | ₹326 | ₹0 | ₹326 (0.00%) |
11 Oct 2025, 17:34 | ₹326 | ₹0 | ₹326 (0.00%) |
10 Oct 2025, 09:16 | ₹326 | ₹5 | ₹331 (1.53%) |
09 Oct 2025, 08:04 | ₹326 | ₹5 | ₹331 (1.53%) |
08 Oct 2025, 12:27 | ₹326 | ₹2 | ₹328 (0.61%) |
07 Oct 2025, 11:10 | ₹326 | ₹4 | ₹330 (1.23%) |
06 Oct 2025, 12:11 | ₹326 | ₹11 | ₹337 (3.37%) |
05 Oct 2025, 06:26 | ₹326 | ₹5 | ₹331 (1.53%) |
04 Oct 2025, 11:29 | ₹326 | ₹7 | ₹333 (2.15%) |
03 Oct 2025, 11:39 | ₹326 | ₹16 | ₹342 (4.91%) |
01 Oct 2025, 07:13 | ₹326 | ₹20 | ₹346 (6.13%) |
30 Sep 2025, 12:03 | ₹326 | ₹14 | ₹340 (4.29%) |
29 Sep 2025, 11:25 | ₹326 | ₹23 | ₹349 (7.06%) |
26 Sep 2025, 15:07 | ₹326 | ₹25 | ₹351 (7.67%) |
25 Sep 2025, 15:21 | ₹326 | ₹51 | ₹377 (15.64%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Tata Capital Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Jun-25 | Mar-25 | Mar-24 |
|---|---|---|---|
EPS | 2.5 | 9.3 | 8.6 |
ROE | 0 | 0 | 0 |
ROCE | 0 | 0 | 0 |
RONW | 3.00 | 11.20 | 13.40 |
PRE IPO(PE) | 0 | 35.99 | 0 |
POST IPO(PE) | 33.24 | 0 | 0 |
Subscription Details (No. of Shares)
The below shows how many shares were subscribed by each investor category in the Tata Capital Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹3,094.55 | 10577.97 | 3.42 |
FIIs | ₹0 | 6133.79 | 0.00 |
FIs | ₹0 | 1801.36 | 0.00 |
Mutual Funds | ₹0 | 1693 | 0.00 |
Others | ₹0 | 949.83 | 0.00 |
RETAIL | ₹5,415.46 | 5939.02 | 1.10 |
HNIs 2+ | ₹773.64 | 1654.85 | 2.14 |
HNIs 10+ | ₹1,547.28 | 2943.94 | 1.90 |
EMPLOYEES | ₹39.12 | 114.34 | 2.92 |
Total | ₹10,870.05 | 21230.12 | 1.95 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
RETAIL | 36,11,272 | 22,99,853 | 0.64 |
EMPLOYEES | 0 | 41,833 | 0.00 |
HNIs(10L +) | 73,699 | 22,362 | 0.30 |
HNIs (2-10L) | 36,850 | 66,301 | 1.80 |
Total | 37,21,821 | 23,88,516 | 0.64 |
The IPO reservation for Tata Capital Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Anchor | 29.92% | 14,23,87,284 |
QIB | 19.95% | 9,49,24,856 |
HNI | 14.96% | 7,11,93,642 |
RETAIL | 34.91% | 16,61,18,498 |
Employee | 0.25% | 12,00,000 |
TOTAL | 100.00% | 47,58,24,280 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 46 | ₹14,996 | |
sHNI | 14 | 644 | ₹2,09,944 | |
bHNI | 67 | 3,082 | ₹10,04,732 |
Below you can find the official contact details of Tata Capital Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: investors@tatacapital.com
Phone: +91 022 6606 900
Website: https://www.tatacapital.com/
Address: 11th Floor, Tower A, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400013 Mumbai, Maharashtra, 400013
IPO Registrar
Name: Link Intime India Private Ltd (MUFG)
Phone: +912249186270
About Company
Our organization excels in various areas and offers a wide range of services...
Strength Factors
- Prominent Market Position with a Diverse Product Offering:A top producer in the fields of medicine, food, nutrition, and unique ingredients (as of June 30, 2025), with a significant focus on mineral-based offerings, iron phosphate, and a diverse array of specialized food ingredients, including encapsulated preservatives.
- State-of-the-Art and Fully Regulated Production Facilities:Runs four plants with 12 production lines located in Gujarat and Ireland, utilizing 68,446 square meters and providing an annual output of 72,246 MT, ensuring effective production processes and adherence to regulations.
- Progress Fueled by Strong R&D Expertise:Features two research and development centers and a team of 41 experts dedicated to particle technology, extending shelf life, improving nutrient absorption, and innovative formulation methods, bolstered by cutting-edge tools to foster advancements in technology, sustainability, and product development.
Risk Factors
- High Reliance on Important Clients:A significant portion of income relies on a small number of clients, which makes the company susceptible to a decrease in orders or the departure of any important customer, potentially affecting its financial health and cash flow.
- Stringent Regulations and Quality Standards:Production facilities are frequently evaluated and must adhere to guidelines set by international organizations like USFDA, EXCiPACT, FSSC, WHO-GMP, ISO, and HACCP. Any inconsistencies, quality issues, or failure to comply could trigger regulatory consequences and damage the firm’s image.
- Potential for Operational Interruptions:Production and research activities may encounter risks from equipment failures, workplace incidents, regulatory challenges, natural disasters, or disease outbreaks. Any interruptions or closures could adversely impact operations, financial outcomes, and cash availability.